Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Engelhardt M, Boccadoro M, Straka C, Brighen S, Gramatzki M, Larocca A, Lokhorst H, Magarotto V, Morabito F, Dimopoulos M, Einsele H, Sonneveld P, Palumbo A, Beksac M, Ludwig H, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, Cavo M, van de Donk N, Beilhack A, Bruno B, Johnsen H, Hájek R, Driessen C, European Myeloma Network. European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica 2014; 99:232-42.
Feb 1, 2014European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Feb 1, 2014Haematologica 2014; 99:232-42
Engelhardt Monika, Boccadoro Mario, Straka Christian, Brighen Sara, Gramatzki Martin, Larocca Alessandra, Lokhorst Henk, Magarotto Valeria, Morabito Fortunato, Dimopoulos Meletios A, Einsele Hermann, Sonneveld Pieter, Palumbo Antonio, Beksac Meral, Ludwig Heinz, Terpos Evangelos, Kleber Martina, Gay Francesca, Wäsch Ralph, Morgan Gareth, Cavo Michele, van de Donk Niels, Beilhack Andreas, Bruno Benedetto, Johnsen Hans Erik, Hájek Roman, Driessen Christoph, European Myeloma Network
Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
Omlin A, Pezaro C, Gillessen Sommer S. Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy. Ther Adv Urol 2014; 6:3-14.
Feb 1, 2014Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy
Feb 1, 2014Ther Adv Urol 2014; 6:3-14
Omlin Aurelius, Pezaro Carmel, Gillessen Sommer Silke
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
Molife L, Pelling K, Temple G, Heath C, Wheatley D, Oommen N, Thompson E, Jenkins P, Hickish T, Pedley I, O'Sullivan J, Olmos D, Fong P, Lumsden G, Bloomfield D, Karavasilis V, Jones R, Omlin A, de Bono J. Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer. Future Oncol 2014; 10:219-31.
Feb 1, 2014Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer
Feb 1, 2014Future Oncol 2014; 10:219-31
Molife L Rhoda, Pelling Katy, Temple Graham, Heath Catherine, Wheatley Duncan, Oommen Nikhil, Thompson Emilda, Jenkins Peter, Hickish Tamas, Pedley Ian, O'Sullivan Joe M, Olmos David, Fong Peter C, Lumsden Graeme, Bloomfield David, Karavasilis Vasilios, Jones Rob J, Omlin Aurelius, de Bono Johann S
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
Decensi A, Coates A, Goldhirsch A, Gelber R, Price K, Johansson H, Zaman K, Schönenberger A, Debled M, Campone M, Monnier A, Tondini C, McIntosh C, Thürlimann B, Guerrieri-Gonzaga A, Sun Z, Aebi S. Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences. Breast Cancer Res Treat 2014; 144:321-9.
Feb 1, 2014Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
Feb 1, 2014Breast Cancer Res Treat 2014; 144:321-9
Decensi Andrea, Coates Alan S, Goldhirsch Aron, Gelber Richard D, Price Karen N, Johansson Harriet, Zaman Khalil, Schönenberger Astrid, Debled Marc, Campone Mario, Monnier Alain, Tondini Carlo, McIntosh Christina, Thürlimann Beat, Guerrieri-Gonzaga Aliana, Sun Zhuoxin, Aebi Stefan
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective
Harbeck N, Wuerstlein R, Welt A, Tesch H, Schneeweiss A, Scharl A, von Minckwitz G, Lück H, Huober J, Jackisch C, Hegewisch-Becker S, Decker T, Untch M, Marschner N, Thomssen C. Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective. Breast Care (Basel) 2014; 9:52-9.
Feb 1, 2014Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective
Feb 1, 2014Breast Care (Basel) 2014; 9:52-9
Harbeck Nadia, Wuerstlein Rachel, Welt Anja, Tesch Hans, Schneeweiss Andreas, Scharl Anton, von Minckwitz Gunter, Lück Hans-Joachim, Huober Jens, Jackisch Christian, Hegewisch-Becker Susanna, Decker Thomas, Untch Michael, Marschner Norbert, Thomssen Christoph
Maligne Hypoglykämie
Rigger J, Kleger G, Semela D, Doenecke C, Rodriguez R, Meyenberger C, Köberle D, Sawatzki M. Maligne Hypoglykämie. Praxis 2014; 103 (7):399-403.
Feb 1, 2014Maligne Hypoglykämie
Feb 1, 2014Praxis 2014; 103 (7):399-403
Rigger Johannes, Kleger Gian Reto, Semela David, Doenecke Christian, Rodriguez Regulo, Meyenberger Christa, Köberle Dieter, Sawatzki Mikael
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda R. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123:2220-8.
Jan 29, 2014Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Jan 29, 2014Blood 2014; 123:2220-8
Lundberg Pontus, Karow Axel, Nienhold Ronny, Looser Renate, Hao-Shen Hui, Nissen Ina, Girsberger Sabine, Lehmann Thomas, Passweg Jakob, Stern Martin, Beisel Christian, Kralovics Robert, Skoda Radek C
Reply from Authors re: Robert J. Hamilton. Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.013: The Stage Is Set for Metformin
Rothermundt C, on behalf of all the authors. Reply from Authors re: Robert J. Hamilton. Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.013: The Stage Is Set for Metformin. Eur Urol 2014
Jan 28, 2014Reply from Authors re: Robert J. Hamilton. Metformin for Castrate-resistant Prostate Cancer: Learning More About an Old Dog's New Tricks. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.013: The Stage Is Set for Metformin
Jan 28, 2014Eur Urol 2014
Rothermundt Christian, on behalf of all the authors
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
McNamara M, Laperriere N, Millar B, Chung C, Bernstein M, Zadeh G, Templeton A, Jiang H, Lwin Z, Mason W. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neurooncol 2014; 117:147-52.
Jan 28, 2014Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
Jan 28, 2014J Neurooncol 2014; 117:147-52
McNamara Mairead G, Laperriere Normand, Millar Barbara-Ann, Chung Caroline, Bernstein Mark, Zadeh Gelareh, Templeton Arnoud, Jiang Haiyan, Lwin Zarnie, Mason Warren P
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Leibowitz-Amit R, de Bono J, Tannock I, Sridhar S, Knox J, Attard G, Seah J, Vera-Badillo F, Keizman D, Atenafu E, Pezaro C, Omlin A, Templeton A, Joshua A. Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer. Ann Oncol 2014; 25:657-62.
Jan 23, 2014Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
Jan 23, 2014Ann Oncol 2014; 25:657-62
Leibowitz-Amit R, de Bono J S, Tannock I F, Sridhar S S, Knox J J, Attard G, Seah J-A, Vera-Badillo F, Keizman D, Atenafu E G, Pezaro C, Omlin Aurelius, Templeton Arnoud, Joshua A M
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
Aebi S, Mamounas E, Geyer C, Price K, Coates A, Gelber R, Rastogi P, Wolmark N, Wapnir I, Murray E, Thürlimann B, Cañada J, Gelber S, Anderson S, Láng I, Robidoux A, Martín M, Nortier J, Paterson A, Rimawi M, CALOR investigators. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol 2014; 15:156-63.
Jan 16, 2014Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
Jan 16, 2014Lancet Oncol 2014; 15:156-63
Aebi Stefan, Mamounas Eleftherios P, Geyer Charles E, Price Karen N, Coates Alan S, Gelber Richard D, Rastogi Priya, Wolmark Norman, Wapnir Irene L, Murray Elizabeth, Thürlimann Beat, Cañada José Manuel Baena, Gelber Shari, Anderson Stewart J, Láng István, Robidoux Andre, Martín Miguel, Nortier Johan W R, Paterson Alexander H G, Rimawi Mothaffar F, CALOR investigators
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer
Lorente D, Chowdhury S, Attard G, Zivi A, Ferraldeschi R, Pezaro C, Omlin A, Rodriguez-Vida A, Bianchini D, de Bono J. Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer. Eur J Cancer 2014; 50:1042-3.
Jan 13, 2014Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer
Jan 13, 2014Eur J Cancer 2014; 50:1042-3
Lorente David, Chowdhury Simon, Attard Gerhardt, Zivi Andrea, Ferraldeschi Roberta, Pezaro Carmel, Omlin Aurelius, Rodriguez-Vida Alejo, Bianchini Diletta, de Bono Johann S
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
Rothermundt C, Cathomas R, Rüschoff J, Schiess R, Endt K, Lui L, Pollak M, Bärtschi D, Strebel R, Winterhalder R, Templeton A, Hayoz S, Gillessen Sommer S. Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). Eur Urol 2014; 66:468-74.
Jan 4, 2014Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
Jan 4, 2014Eur Urol 2014; 66:468-74
Rothermundt Christian, Cathomas Richard, Rüschoff Jan H, Schiess Ralph, Endt Kathrin, Lui Lillianne, Pollak Michael, Bärtschi Daniela, Strebel Räto T, Winterhalder Ralph, Templeton Arnoud, Hayoz Stefanie, Gillessen Sommer Silke
Maligne spinale Kompression
Omlin A, Stienen M, Brügge D, Fretz C, Gillessen Sommer S, Hundsberger T. Maligne spinale Kompression - Prävention, Erkennung und «State of the Art»-Behandlung. SMF 2014; 14:820-825.
Jan 1, 2014Maligne spinale Kompression
Jan 1, 2014SMF 2014; 14:820-825
Omlin Aurelius, Stienen Martin N., Brügge Detlef, Fretz Christian, Gillessen Sommer Silke, Hundsberger Thomas
Strategy on Patients with EGFR Mutation
Früh M. Strategy on Patients with EGFR Mutation. In: New Therapeutic Strategies in Lung Cancers. Heidelberg: Springer, 2014. ISBN 978-3-319-06061-3. pp. 133-145.
Jan 1, 2014Strategy on Patients with EGFR Mutation
Jan 1, 2014Springer, ISBN 978-3-319-06061-3
Früh Martin
Advances in Radiotherapy for Locally Advanced NSCLC
Früh M. Advances in Radiotherapy for Locally Advanced NSCLC. In: New Therapeutic Strategies in Lung Cancers. Heidelberg: Springer, 2014. ISBN 978-3-319-06061-3. pp. 69-94.
Jan 1, 2014Advances in Radiotherapy for Locally Advanced NSCLC
Jan 1, 2014Springer, ISBN 978-3-319-06061-3
Früh Martin
Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib
Leitner C, von Moos R, Früh M, Mark M, Cathomas R. Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib. Cancer Treatment Communications 2014; 2:4-7.
Jan 1, 2014Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib
Jan 1, 2014Cancer Treatment Communications 2014; 2:4-7
Leitner C, von Moos Roger, Früh Martin, Mark M, Cathomas R
Hoffnung und Gnade
Renz M. Hoffnung und Gnade - Erfahrung von Transzendenz in Leid und Krankheit. Spiritual Care. Freiburg i.Br.: Kreuz, 2014. ISBN 978-3-451-61304-3.
Jan 1, 2014Hoffnung und Gnade
Jan 1, 2014Kreuz, ISBN 978-3-451-61304-3
Renz Monika
Nervensonographie intraneuraler Ganglien als Ursache schmerzhafter N.-peronaeus-Paresen: eine Fallserie
Schilg-Hafer L, Hägele-Link S, Felbecker A, Weber J, Tettenborn B, Gers B, Hundsberger T. Nervensonographie intraneuraler Ganglien als Ursache schmerzhafter N.-peronaeus-Paresen: eine Fallserie. Praxis 2014; 24:1433-1438.
Jan 1, 2014Nervensonographie intraneuraler Ganglien als Ursache schmerzhafter N.-peronaeus-Paresen: eine Fallserie
Jan 1, 2014Praxis 2014; 24:1433-1438
Schilg-Hafer Lenka, Hägele-Link Stefan, Felbecker Ansgar, Weber Johannes, Tettenborn Barbara, Gers Bettina, Hundsberger Thomas
5 Jahre Bevacizumab beim Glioblastom
Hundsberger T. 5 Jahre Bevacizumab beim Glioblastom - Eine unverzichtbare. 2014
Jan 1, 20145 Jahre Bevacizumab beim Glioblastom
Jan 1, 20142014
Hundsberger Thomas